Last updated on February 2019

A Dose Escalation Study of Bradanicline in Refractory Chronic Cough

Brief description of study

This is a randomized, double-blind, placebo-controlled, crossover, dose escalation study of bradanicline in subjects with chronic cough

Detailed Study Description

This study will have two 21-day treatment periods separated by a 14-day washout period. There will be a 14-day follow-up period.

Clinical Study Identifier: NCT03622216

Contact Investigators or Research Sites near you

Start Over

Study coordinator

Atlantic Research Center, LLC
Ocean Township, NJ United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.